novel coronavirus pneumonia,chronic liver disease
Conditions
Interventions
The anticoagulant group was used:N/A
No anticoagulant drugs were used:N/A
Sponsors
The Third Hosptial of Zhenjiang Affiliated Jiangsu University
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: 1. No age limitation, no gender limitation; 2. Diagnostic criteria: Diagnostic criteria for patients with novel coronavirus infection Reference: Diagnosis and treatment Protocol for novel coronavirus infection (trial version 10) : (1) Clinical manifestations related to COVID-19 infection; (2) Have one or more of the following etiological and serological test results: 1) COVID-19 nucleic acid test is positive; 2) Test positive for COVID-19 antigen; 3) Isolation and culture of the novel coronavirus are positive; 4) The level of novel coronavirus specific IgG antibody increased 4 times or more in the convalescent phase than in the acute phase. 3. Patients with chronic liver disease, such as chronic hepatitis B (CHB), alcoholic fatty liver disease (AFID), non-alcoholic fatty liver disease (NAFID), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), cirrhosis, liver cancer, etc. Diagnostic criteria refer to the guidelines for specific diseases.
Exclusion criteria
Exclusion criteria: Any one of the following is not eligible: 1. Incomplete clinical data; 2. Patients with mental disorders and other serious diseases; 3. Withdrawal and lost visitors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| D-dimer;PT;APTT;fibrinogen;INR;ALT;AST;ALP;WBC;PLT;Hb;B ultrasound;Chest and abdominal CT; | — |
Countries
China
Contacts
Public ContactTan Youwen
The Third Hosptial of Zhenjiang Affiliated Jiangsu University
Outcome results
None listed